Schubert & CO Sage Therapeutics, Inc. Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$32.2 - $43.61 $322 - $436	-10 Reduced 24.39%	31 $1,000
Q3 2022 Oct 21, 2022	BUY	$32.28 - $43.27 $871 - $1,168	27 Added 192.86%	41 $2,000
Q2 2022 Aug 01, 2022	BUY	$27.52 - $37.99 $275 - $379	10 Added 250.0%	14 $0
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $61 - $91	2 Added 100.0%	4 $0
Q4 2021 Jan 28, 2022	BUY	$37.06 - $47.11 $74 - $94	2 New	2 $0

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.